
Glucose Biosensors
Description
Global Glucose Biosensors Market to Reach US$4.1 Billion by 2030
The global market for Glucose Biosensors estimated at US$3.6 Billion in the year 2024, is expected to reach US$4.1 Billion by 2030, growing at a CAGR of 2.1% over the analysis period 2024-2030. Hospitals, one of the segments analyzed in the report, is expected to record a 1.8% CAGR and reach US$1.5 Billion by the end of the analysis period. Growth in the Homecare Diagnostics segment is estimated at 2.5% CAGR over the analysis period.
The U.S. Market is Estimated at US$980.3 Million While China is Forecast to Grow at 3.1% CAGR
The Glucose Biosensors market in the U.S. is estimated at US$980.3 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$765.6 Million by the year 2030 trailing a CAGR of 3.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.4% and 1.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.8% CAGR.
Global Glucose Biosensors Market - Key Trends and Drivers Summarized
How Are Glucose Biosensors Enhancing Diabetes Management?
Glucose biosensors are critical tools in the management of diabetes, providing real-time monitoring of blood glucose levels for patients. These sensors, which are integral to glucose meters and continuous glucose monitoring (CGM) devices, measure the concentration of glucose in the blood using enzymatic reactions and electrochemical detection methods. Continuous glucose monitoring systems, which offer around-the-clock tracking, have significantly improved diabetes management by providing patients with more data to make informed decisions about their insulin dosing, diet, and activity. With the rising prevalence of diabetes worldwide, the demand for accurate, reliable, and user-friendly glucose biosensors is on the rise, helping patients maintain better control over their condition.
What Are the Key Segments and Applications of Glucose Biosensors?
The glucose biosensors market is segmented by technology, including electrochemical, optical, and enzymatic biosensors. Electrochemical biosensors, which measure glucose concentration through electrical signals generated by enzymatic reactions, dominate the market due to their accuracy, affordability, and widespread use in CGM devices and glucose meters. Optical biosensors, which use light-based detection methods, are also gaining traction, particularly for non-invasive monitoring systems. In terms of application, glucose biosensors are primarily used in self-monitoring blood glucose (SMBG) systems and continuous glucose monitoring devices. Hospitals, clinics, and home healthcare settings represent the primary end-users. North America leads the market due to the high prevalence of diabetes and advanced healthcare infrastructure, while Asia-Pacific is experiencing rapid growth as diabetes rates rise and access to healthcare improves.
How Are Technological Advancements Impacting Glucose Biosensors?
Technological innovations are driving improvements in glucose biosensors, particularly in the areas of non-invasive monitoring, sensor accuracy, and integration with digital health platforms. Continuous glucose monitoring (CGM) systems, which provide real-time data through wearable sensors, have transformed diabetes management by reducing the need for frequent finger-prick tests. Advances in sensor miniaturization, biocompatible materials, and wireless connectivity are making these devices more comfortable and convenient for patients. The integration of glucose biosensors with mobile apps and cloud platforms is enabling patients and healthcare providers to track trends and make data-driven decisions. Additionally, research into non-invasive glucose monitoring methods, such as optical and transdermal sensors, holds promise for the future of diabetes care.
What Factors Are Driving the Growth in the Glucose Biosensors Market?
The growth in the glucose biosensors market is driven by several factors, including the rising global prevalence of diabetes and the increasing demand for continuous, real-time glucose monitoring solutions. Advances in biosensor technology, including improvements in sensor accuracy, miniaturization, and non-invasive monitoring techniques, are enhancing the patient experience and expanding the use of glucose biosensors in both clinical and home settings. Government initiatives and healthcare policies aimed at improving diabetes management are further supporting the adoption of advanced glucose monitoring devices. The growing integration of glucose biosensors with digital health platforms, enabling better patient-provider communication and data analysis, is also fueling market growth.
SCOPE OF STUDY:The report analyzes the Glucose Biosensors market in terms of units by the following Segments, and Geographic Regions/Countries:
Segments:
End-Use (Hospitals, Homecare Diagnostics, Other End-Uses)
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Select Competitors (Total 42 Featured) -
- Abbott Laboratories
- ACON Laboratories, Inc.
- AgaMatrix Inc.
- Bayer
- Biacore
- BioSense Medical Devices, LLC
- Biosensors International Pte. Ltd.
- LifeScan, Inc.
- LifeSensors, Inc.
- Medtronic, Inc.
- Nova Biomedical
- Pharmaco-Kinesis Corporation
- Pinnacle Medical Solutions, Inc.
- Roche Diagnostics
- Sanofi S.A.
We`re transforming market and competitive intelligence with validated expert content and AI tools.
Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.
The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.
Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.
Table of Contents
- I. METHODOLOGY
- II. EXECUTIVE SUMMARY
- 1. MARKET OVERVIEW
- Influencer Market Insights
- Tariff Impact on Global Supply Chain Patterns
- Global Economic Update
- Glucose Biosensors – Global Key Competitors Percentage Market Share in 2025 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
- 2. FOCUS ON SELECT PLAYERS
- 3. MARKET TRENDS & DRIVERS
- Rising Prevalence of Diabetes Globally Propels Demand for Glucose Biosensors
- Technological Innovations in Continuous Glucose Monitoring (CGM) Devices Strengthen Market Growth
- Increasing Adoption of Wearable Glucose Biosensors Drives Market Expansion
- Growing Focus on Non-Invasive Glucose Monitoring Technologies Creates Opportunities
- Rising Demand for Portable and Convenient Glucose Monitoring Devices Expands Addressable Market
- Advancements in Sensor Accuracy and Reliability Propel Adoption of Glucose Biosensors
- Increasing Integration of Biosensors with Mobile Apps and Cloud Platforms Boosts Demand
- Rising Adoption of Glucose Biosensors in Personalized Medicine Strengthens Business Case
- Growing Preference for Continuous Glucose Monitoring over Traditional Testing Methods Drives Growth
- Technological Developments in Miniaturized and Implantable Biosensors Spur Innovation
- Rising Demand for Real-Time Monitoring Solutions in Healthcare Expands Market for Biosensors
- Growing Healthcare Expenditure and Insurance Coverage for Diabetes Management Support Market Growth
- 4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World Recent Past, Current & Future Analysis for Glucose Biosensors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 2: World Historic Review for Glucose Biosensors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 3: World 15-Year Perspective for Glucose Biosensors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
- TABLE 4: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 5: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 6: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 7: World Recent Past, Current & Future Analysis for Homecare Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 8: World Historic Review for Homecare Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 9: World 15-Year Perspective for Homecare Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 10: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 11: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 12: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 13: World Glucose Biosensors Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
- III. MARKET ANALYSIS
- UNITED STATES
- Glucose Biosensors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
- TABLE 14: USA Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 15: USA Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 16: USA 15-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2015, 2025 & 2030
- CANADA
- TABLE 17: Canada Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 18: Canada Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 19: Canada 15-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2015, 2025 & 2030
- JAPAN
- Glucose Biosensors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
- TABLE 20: Japan Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 21: Japan Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 22: Japan 15-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2015, 2025 & 2030
- CHINA
- Glucose Biosensors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
- TABLE 23: China Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 24: China Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 25: China 15-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2015, 2025 & 2030
- EUROPE
- Glucose Biosensors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
- TABLE 26: Europe Recent Past, Current & Future Analysis for Glucose Biosensors by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 27: Europe Historic Review for Glucose Biosensors by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 28: Europe 15-Year Perspective for Glucose Biosensors by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
- TABLE 29: Europe Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 30: Europe Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 31: Europe 15-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2015, 2025 & 2030
- FRANCE
- Glucose Biosensors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
- TABLE 32: France Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 33: France Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 34: France 15-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2015, 2025 & 2030
- GERMANY
- Glucose Biosensors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
- TABLE 35: Germany Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 36: Germany Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 37: Germany 15-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2015, 2025 & 2030
- ITALY
- TABLE 38: Italy Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 39: Italy Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 40: Italy 15-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2015, 2025 & 2030
- UNITED KINGDOM
- Glucose Biosensors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
- TABLE 41: UK Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 42: UK Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 43: UK 15-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2015, 2025 & 2030
- SPAIN
- TABLE 44: Spain Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 45: Spain Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 46: Spain 15-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2015, 2025 & 2030
- RUSSIA
- TABLE 47: Russia Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 48: Russia Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 49: Russia 15-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2015, 2025 & 2030
- REST OF EUROPE
- TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 51: Rest of Europe Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 52: Rest of Europe 15-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2015, 2025 & 2030
- ASIA-PACIFIC
- Glucose Biosensors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
- TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Glucose Biosensors by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 54: Asia-Pacific Historic Review for Glucose Biosensors by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 55: Asia-Pacific 15-Year Perspective for Glucose Biosensors by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
- TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 57: Asia-Pacific Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 58: Asia-Pacific 15-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2015, 2025 & 2030
- AUSTRALIA
- Glucose Biosensors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
- TABLE 59: Australia Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 60: Australia Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 61: Australia 15-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2015, 2025 & 2030
- INDIA
- Glucose Biosensors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
- TABLE 62: India Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 63: India Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 64: India 15-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2015, 2025 & 2030
- SOUTH KOREA
- TABLE 65: South Korea Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 66: South Korea Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 67: South Korea 15-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2015, 2025 & 2030
- REST OF ASIA-PACIFIC
- TABLE 68: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 69: Rest of Asia-Pacific Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 70: Rest of Asia-Pacific 15-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2015, 2025 & 2030
- LATIN AMERICA
- Glucose Biosensors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
- TABLE 71: Latin America Recent Past, Current & Future Analysis for Glucose Biosensors by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 72: Latin America Historic Review for Glucose Biosensors by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 73: Latin America 15-Year Perspective for Glucose Biosensors by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
- TABLE 74: Latin America Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 75: Latin America Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 76: Latin America 15-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2015, 2025 & 2030
- ARGENTINA
- TABLE 77: Argentina Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 78: Argentina Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 79: Argentina 15-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2015, 2025 & 2030
- BRAZIL
- TABLE 80: Brazil Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 81: Brazil Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 82: Brazil 15-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2015, 2025 & 2030
- MEXICO
- TABLE 83: Mexico Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 84: Mexico Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 85: Mexico 15-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2015, 2025 & 2030
- REST OF LATIN AMERICA
- TABLE 86: Rest of Latin America Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 87: Rest of Latin America Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 88: Rest of Latin America 15-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2015, 2025 & 2030
- MIDDLE EAST
- Glucose Biosensors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
- TABLE 89: Middle East Recent Past, Current & Future Analysis for Glucose Biosensors by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 90: Middle East Historic Review for Glucose Biosensors by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 91: Middle East 15-Year Perspective for Glucose Biosensors by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
- TABLE 92: Middle East Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 93: Middle East Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 94: Middle East 15-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2015, 2025 & 2030
- IRAN
- TABLE 95: Iran Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 96: Iran Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 97: Iran 15-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2015, 2025 & 2030
- ISRAEL
- TABLE 98: Israel Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 99: Israel Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 100: Israel 15-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2015, 2025 & 2030
- SAUDI ARABIA
- TABLE 101: Saudi Arabia Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 102: Saudi Arabia Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 103: Saudi Arabia 15-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2015, 2025 & 2030
- UNITED ARAB EMIRATES
- TABLE 104: UAE Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 105: UAE Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 106: UAE 15-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2015, 2025 & 2030
- REST OF MIDDLE EAST
- TABLE 107: Rest of Middle East Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 108: Rest of Middle East Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 109: Rest of Middle East 15-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2015, 2025 & 2030
- AFRICA
- Glucose Biosensors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
- TABLE 110: Africa Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 111: Africa Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 112: Africa 15-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2015, 2025 & 2030
- IV. COMPETITION
Pricing
Currency Rates